ReviewInfection2026
Contemporary diagnostic strategies for blood culture-negative infective endocarditis: from conventional microbiology to emerging molecular and multimodality approaches.
Review in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBlood culture-negative infective endocarditis (BCNE) remains one of the most challenging presentations of infective endocarditis (IE) because the absence of microbiological confirmation delays diagnosis and complicates therapeutic management. BCNE may result from prior antibiotic exposure, infection with fastidious or intracellular microorganisms, fungal pathogens, or non-infectious conditions mimicking IE.
methodsThis narrative review provides a clinically oriented overview of contemporary diagnostic strategies for BCNE based on current evidence and recent international guidelines. The diagnostic performance, limitations, and clinical applicability of biomarkers, microbiological methods, multimodality imaging, and pathological analysis were critically evaluated and integrated into practical diagnostic algorithms.
resultsTargeted serology and polymerase chain reaction (PCR), particularly on excised valve tissue, remain the most clinically validated microbiological tools for routine BCNE diagnosis. Emerging molecular approaches, including droplet digital PCR (ddPCR) and metagenomic next-generation sequencing (mNGS), show promising diagnostic potential but remain insufficiently standardized for routine implementation. Echocardiography remains the first-line imaging modality, while cardiac computed tomography, 18 F-FDG PET/CT, and white blood cell SPECT/CT (WBC SPECT/CT) provide complementary diagnostic information, particularly in prosthetic valve endocarditis (PVE) and other diagnostically challenging cases. Histopathological examination combined with molecular analysis of surgical specimens remains an important complementary diagnostic approach when valve tissue is available.
conclusionsOptimal diagnosis of BCNE requires an integrated multidisciplinary strategy combining clinical assessment, microbiology, multimodality imaging, and pathology. Future progress will depend on evidence-based diagnostic algorithms integrating emerging technologies according to their level of validation, local epidemiology, and available expertise.
Indexed as
Identifiers
42747765What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.